Clinical Trials on β-thalassemia Major in Norway
Total 33 results
-
Haukeland University HospitalUniversity of BergenRecruitingHealthy | Major Depressive Disorder | Major Depressive Disorder 1Norway
-
Diakonhjemmet HospitalMD Tor Magne Bjølseth; MD Torfinn Lødøen GaardenCompleted
-
Haukeland University HospitalUniversity of BergenRecruitingCognitive Impairment | Cognitive Remediation | Major Depression in RemissionNorway
-
University of OsloRecruiting
-
Norwegian University of Science and TechnologyCompletedMajor Depressive DisorderNorway
-
University of OsloDiakonhjemmet Hospital; University of Oxford; ExtrastiftelsenCompletedMajor Depressive DisorderNorway
-
University of OsloOslo University Hospital; University of OxfordCompleted
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedDepressive Disorder | Depressive Disorder, MajorNorway
-
Oslo University HospitalUnknownGender DysphoriaNorway
-
University Hospital, AkershusUniversity of Oslo; Children's Hospital of Philadelphia; Helse Sor-OstTerminatedDepressive Disorder | Major Depression | Mood DisorderNorway
-
Helse Stavanger HFThe Research Council of NorwayTerminatedDepressive Disorder | Major Depression | Mood DisorderNorway
-
University of OsloDiakonhjemmet Hospital; University of Oxford; Sorlandet Hospital HFCompleted
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; University of Oxford; The Hospital of... and other collaboratorsCompleted
-
NeuroneticsCompletedMajor Depressive DisorderUnited States
-
Neumora Therapeutics, Inc.RecruitingMajor Depressive DisorderUnited States, Canada
-
GlaxoSmithKlineCompletedDepressive Disorder, MajorBelgium, Australia, Russian Federation, Netherlands, Norway, Finland
-
AstraZenecaCompletedMajor Depressive DisorderSweden, Czech Republic, France, Germany, Poland, Romania, Finland, Norway, Belgium, Canada, Australia, South Africa
-
H. Lundbeck A/SCompletedMajor Depressive DisorderUkraine, Lithuania, France, Austria, Russian Federation, Australia, Belgium, Canada, Czech Republic, Finland, India, Korea, Republic of, Malaysia, Norway, Philippines, Serbia, Sweden
-
AstraZenecaCompleted
-
TakedaCompletedMajor Depressive DisorderUnited States
-
ShireCompletedMajor Depressive DisorderUnited States, Spain, Canada, Puerto Rico, Croatia, Mexico
-
AstraZenecaTargacept Inc.CompletedDepression | Major Depressive Disorder | MDDUnited States, Puerto Rico
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorUnited States
-
AstraZenecaTargacept Inc.CompletedDepression | Major Depressive DisorderUnited States, India, Puerto Rico
-
Janssen Research & Development, LLCTerminatedDepressive Disorder, MajorUnited States, Korea, Republic of, Malaysia, Poland, Finland, Chile, Argentina, Slovakia, Ukraine, Denmark
-
Janssen-Cilag International NVCompletedDepressive Disorder, MajorIsrael, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, MajorUnited States, France, Poland, Canada, Slovakia
-
TakedaCompletedDepressive Disorder, MajorUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, MajorUnited States, France, Poland, Russian Federation, Romania, Ukraine, Germany, Hungary, Slovakia, Serbia, Canada
-
TakedaCompletedDepressive Disorder, MajorUnited States, Ukraine, Germany, Poland, Bulgaria, Finland, Russian Federation
-
Region StockholmUppsala UniversityRecruitingStroke | Chronic Kidney Diseases | Death | Atrial Fibrillation | Intracerebral Hemorrhage | Kidney Transplant; Complications | Thromboses, Venous | Cardiovascular Complication | Major BleedSweden, Norway, Finland, Iceland
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Oropharyngeal Squamous... and other conditionsUnited States, Puerto Rico, South Africa